Manufacturing and Production

Showing 15 posts of 5869 posts found.

Sanofi to move away from diabetes and cardiovascular, as company shakeup continues

December 10, 2019 Manufacturing and Production ASH 19, Sanofi, Sanofi Diabetes, Sanofi Insulin, diabetes, insulin

Sanofi has said it will stop investment and research into creating new diabetes and cardiovascular drugs, as part of the …
samsung_bioepis

South Korea jails executives for their role in Samsung Biologics fraud

December 10, 2019 Manufacturing and Production Samsung phones, Sanofi, Sanofi Diabetes, South Korea Healthcare System, South Korea Samsung, diabetes, inhaled insulin, insulin, south korea

Three executives of Samsung Electronics have been sentenced to jail for their role in committing fraud at its biotech affiliate …
janssen_latest_logo_on_sign

Janssen’s Darzalex combo shows strong overall survival benefit at ASH 2019

December 10, 2019 Manufacturing and Production, Research and Development ASH 19, Janssen, darzalex, pharma

Janssen has unveiled new Phase 3 data on the efficacy of Darzalex (daratumumab) when combined with bortezomib, melphalan and prednisone …

Pfizer and Sangamo’s haemophilia gene therapy shows increased factor VIII levels

December 9, 2019 Manufacturing and Production, Sales and Marketing American Society of Hematology, Pfizer, Sangamo Therapeutics, hematology

Pfizer and Sangamo Therapeutics have revealed that their investigational gene therapy, SB-525, sustained increased factor VIII (FVIII) levels in patients …
shutterstock_138095450

Transactions in the pharma sector: Through the EU merger review looking-glass

December 9, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, feature, mergers & acquisitions, pharma

With mergers and acquisitions back in full swing after a period of drought, Alec Burnside (Partner) and Delphine Strohl (Associate) …
top_10_image_43_0

Top Ten most popular articles on Pharmafile.com this week

December 6, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, NHS, corruption, lung cancer, opiods crisis, opioids

Corruption and bribery feature heavily in the news this week. A recently exposed 1997 email chain shows Dr Richard Sackler, …

Partnership with payers: Communicating and negotiating with impact

December 6, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA, market access, pharma

NDA’s Lisa Peluso, Director, Coaching and Client Engagement, outlines key strategies for interacting with audiences and payers while maximising team …
dr-torbett-696x464

Dr Richard Torbett is named as the new Chief Executive of the ABPI

December 5, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The Association of the British Pharmaceutical Industry (ABPI) has appointed Dr Richard Torbett as its new Chief Executive. He will …
diazepam

Seizures of black market diazepam tablets double in the UK in a year

December 5, 2019 Manufacturing and Production Border Force, Diazepam, NHS, anxiety, opioids

The number of illegal diazepam tablets seized by the UK Border Force has doubled in a year, going from 545,000 …
image3

Patient experience: Living with desmoid fibromatosis

December 4, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing desmoid fibrosis, feature, patient experience, pharma, rare disease

Lisa Pascoe lives with a rare, benign desmoid tumour in her abdomen. She opens up to Pharmafocus on her diagnosis …
920x920

Purdue Pharma’s Richard Sackler ignored OxyContin addiction concerns, new emails show

December 3, 2019 Manufacturing and Production, Sales and Marketing Opiod, Purdue Pharma, Richard Sackler, opiod crisis

A recently exposed 1997 email chain shows Dr Richard Sackler, member of the billionaire founding family of Purdue Pharma, knew …
astrazeneca_plaque

AstraZeneca sells US/Canada rights for Seroquel for $41 million to “focus on main therapy areas”

December 3, 2019 Manufacturing and Production, Sales and Marketing AstraZeneca, pharma

AstraZeneca has announced its intention to jettison the rights to two non-core drugs in the US and Canada in order …
showimage

Jeremy Corbyn writes Trump letter asking for reassurance over NHS in trade deal

December 3, 2019 Manufacturing and Production Boris, Boris Johnson, Boris NHS, Jeremy Corbyn, Labour Party, NHS, Trump

Labour Party leader Jeremy Corbyn has written to US President Donald Trump demanding he confirm that he will not put …
ap_01101003057-1024x672

Reagan-era FDA Commissioner Frank Young dies

December 3, 2019 Manufacturing and Production FDA, FDA commissioner, Frank Young

Frank Young, FDA Commissioner from 1984-1989, died on 24 November. He was 88; his son, Jonathan, said the cause was …

Astellas poised to acquire neuromuscular disease specialist Audentes for $3bn all-cash

December 3, 2019 Manufacturing and Production, Sales and Marketing Astellas, Audentes, acquisition, neuromuscular disease, pharma

Astellas Pharma is set to acquire US-based Audentes Therapeutics in an all-cash deal valued at $3 billion in cash, it …
The Gateway to Local Adoption Series

Latest content